UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.15, sa.4, ss.199-202, 2005 (SCI-Expanded)
Neurologic paraneoplastic syndromes are rare in patients with ovarian cancer. These syndromes may point out an occult or relapsed disease. The management of the majority of neurologic paraneoplastic syndromes is difficult because no standard treatment is available but some type of them may subside with the treatment of underlying cancer. We present a case of neurologic paraneoplastic syndrome as a first symptom of relapsed ovarian cancer. However, we could not specify the syndrome with its clinical features and electrophysiological study. It subsided greatly following the cytotoxic chemotherapy for ovarian cancer and re-occured with the appearance of resistance to chemotherapy.